Cargando…
Treatment with synthetic β-lactoglobulin peptides can prevent clinical symptoms in a mouse model for cow’s milk allergy
Autores principales: | Meulenbroek, L, van Esch, B, Hofman, G, Nauta, A, Willemsen, L, Bruijnzeel-Koomen, C, Garssen, J, van Hoffen, E, Knippels, L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723643/ http://dx.doi.org/10.1186/2045-7022-3-S3-P83 |
Ejemplares similares
-
A Specific Mixture of Fructo-Oligosaccharides and Bifidobacterium breve M-16V Facilitates Partial Non-Responsiveness to Whey Protein in Mice Orally Exposed to β-Lactoglobulin-Derived Peptides
por: Kostadinova, Atanaska I., et al.
Publicado: (2017) -
Oral pretreatment with β-lactoglobulin derived peptide and CpG co-encapsulated in PLGA nanoparticles prior to sensitizations attenuates cow’s milk allergy development in mice
por: Liu, Mengshan, et al.
Publicado: (2023) -
Multicenter validation of a mouse model for cow's milk allergy to assess the allergenicity of hydrolysed cow's milk based infant formulae
por: van Esch, BCAM, et al.
Publicado: (2013) -
Inhibition of cow’s milk allergy development in mice by oral delivery of β‐lactoglobulin‐derived peptides loaded PLGA nanoparticles is associated with systemic whey‐specific immune silencing
por: Liu, Mengshan, et al.
Publicado: (2021) -
The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models
por: Vonk, Marlotte M., et al.
Publicado: (2017)